Related Experiment Video
Updated: Sep 7, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Cirrhosis and fungal infections-a cocktail for catastrophe: A systematic review and meta-analysis with machine
Nipun Verma1, Shreya Singh2, Akash Roy1
1Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Objectives:
We evaluated the magnitude and factors contributing to poor outcomes among cirrhosis patients with fungal infections (FIs).
Methods:
We searched PubMed, Embase, Ovid and WOS and included articles reporting mortality in cirrhosis with FIs. We pooled the point and relative-risk (RR) estimates of mortality on random-effects meta-analysis and explored their heterogeneity (I 2 ) on subgroups, meta-regression and machine learning (ML). We assessed the study quality through New-Castle-Ottawa Scale and estimate-asymmetry through Eggers regression. (CRD42019142782).
Results:
Of 4345, 34 studies (2134 patients) were included (good/fair/poor quality: 12/21/1). Pooled mortality of FIs was 64.1% (95% CI: 55.4-72.0, I 2 : 87%, p < .01), which was 2.1 times higher than controls (95% CI: 1.8-2.5, I 2 :89%, p < .01). Higher CTP (MD: +0.52, 95% CI: 0.27-0.77), MELD (MD: +2.75, 95% CI: 1.21-4.28), organ failures and increased hospital stay (30 vs. 19 days) were reported among cases with FIs. Patients with ACLF (76.6%, RR: 2.3) and ICU-admission (70.4%, RR: 1.6) had the highest mortality. The risk was maximum for pulmonary FIs (79.4%, RR: 1.8), followed by peritoneal FIs (68.3%, RR: 1.7) and fungemia (55%, RR: 1.7). The mortality was higher in FIs than in bacterial (RR: 1.7) or no infections (RR: 2.9). Estimate asymmetry was evident (p < 0.05). Up to 8 clusters and 5 outlier studies were identified on ML, and the estimate-heterogeneity was eliminated by excluding such studies.
Conclusions:
A substantially worse prognosis, poorer than bacterial infections in cirrhosis patients with FIs, indicates an unmet need for improving fungal diagnostics and therapeutics in this population. ACLF and ICU admission should be included in the host criteria for defining IFIs.
Insights
Fungal infections (FIs) in cirrhosis patients lead to significantly higher mortality, especially with acute-on-chronic liver failure (ACLF) or ICU admission. This highlights an urgent need for better fungal diagnostics and treatments in this vulnerable group.
Area of Science:
- Medical Mycology
- Hepatology
- Critical Care Medicine
Background:
- Cirrhosis patients face increased susceptibility to infections.
- Fungal infections (FIs) represent a significant, yet often underestimated, threat in this population.
- Understanding the outcomes of FIs in cirrhosis is crucial for improving patient management.
Purpose of the Study:
- To quantify the mortality associated with fungal infections in cirrhosis patients.
- To identify factors contributing to poor outcomes in these patients.
- To compare the prognosis of fungal infections with other infections in cirrhosis.
Main Methods:
- A systematic literature search was conducted across major databases (PubMed, Embase, WOS).
- Random-effects meta-analysis was used to pool mortality estimates and relative risks (RR).
- Subgroup analysis, meta-regression, and machine learning (ML) were employed to explore heterogeneity and identify outliers.
Main Results:
- The pooled mortality for fungal infections in cirrhosis was 64.1%, 2.1 times higher than controls.
- Higher CTP and MELD scores, organ failures, and longer hospital stays were associated with FIs.
- Mortality was highest in patients with acute-on-chronic liver failure (ACLF) and ICU admission, and for pulmonary FIs.
Conclusions:
- Fungal infections portend a worse prognosis than bacterial infections in cirrhosis patients.
- There is a critical unmet need for improved diagnostics and therapeutics for FIs in this population.
- ACLF and ICU admission should be incorporated into criteria for defining invasive fungal infections (IFIs).
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Fungal Phylum Microsporidia
Chronic Pancreatitis II: Collaborative Care
Assessment: